GE HealthCare Results Top Estimates But Firm Cuts Profit Outlook Over Tariffs

GE HealthCare Technologies (GEHC) on Wednesday posted first-quarter results that came in better than analysts had expected, but the former General Electric division lowered its full-year profit outlook because of tariffs.

The medical device maker reported adjusted earnings per share of $1.01 on revenue that increased 3% year-over-year to $4.78 billion. Analysts polled by Visible Alpha had forecast $0.92 and $4.66 billion, respectively.

Adjusted EPS Forecast Lowered Due to $0.85-Per-Share Tariff Impact

However, GE HealthCare lowered its full-year adjusted EPS forecast because of announced tariffs, which it said will have an impact of $0.85 per share. The company said it now expects adjusted EPS of $3.90 to $4.10, down from the prior range of $4.61 to $4.75. It still expects organic revenue growth of 2% to 3%.

“Regarding the current global trade environment, we are actively driving mitigation actions,” CEO Peter Arduini said. “We continue to see strong customer demand in many of the markets we serve and are well-positioned to drive long-term value as we invest in future innovation.”

Also on Wednesday, the company said its board has approved a stock buyback plan of up to $1 billion.

GE HealthCare shares rose 4% shortly after Wednesday’s report was released. Entering the day, they had lost about 13% of their value since the start of the year.

Last week, the firm’s former corporate brethren GE Vernova (GEV) and GE Aerospace (GE) topped Q1 estimates and affirmed their full-year outlooks.